Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019158 (
hepatitis
)
30,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 4-year-old girl developed severe
hepatitis
following the fourth administration of halothane in a period of 5 months.
She
was shown to have a circulating antibody which acted specifically against rabbit hepatocyte previously sensitized to halothane. The patient made a full recovery from the
hepatitis
, but 5 months later, developed diabetes mellitus.
...
PMID:Halothane hepatitis in a young child. 706 30
A case is described wherein a 29 year old woman was admitted to the hospital because of the possibility of a hepatic tumor; symptoms included abdominal pain, diffuse hepatic enlargement and absence of uptake in an area of the right hepatic lobe. After a normal pregnancy and delivery 11 years earlier the patient used oral contraceptives (OCs) composed of norethindrone with mestranol until 8 years before entry; 5 years before admission she resumed use of an OC containing norethindrone and ethinyl estradiol.
She
smoked 1.5 packages of cigarettes and drank 1 glass of wine daily, and there was no history of nausea, vomiting, melena, jaundice, dark urine, light stools,
hepatitis
, or blood transfusions. Benign lesions which are known to be caused by OCs fall into 2 groups: designated focal nodular hyperplasia and liver-cell adenoma. The evidence linking the latter with OCs is more convincing since in case-controlled studies the risk of development of adenomas has been shown to increase with the estrogen strength of the OCs and duration of use; in women who have been taking OCs over 7 years the relative risk is 500 times that for matched control nonusers. The vascular complications of OC therapy include Budd-Chiari syndrome, peliosis hepatis, and periportal sinusoidal dilatation. The patient in this case was diagnosed to have periportal and midzonal hepatic sinusoidal dilatation association with OC medication.
She
underwent an operation on her liver which proved to be successful combined with cessation of OC use. The mechanism by which OCs cause these lesions is not known. In 5 of 13 cases similar to the one described here clinical and biochemical abnormalities resolved and 1 patient had a follow-up liver biopsy that revealed normal findings 10 months after cessation of OC therapy; there is no evidence to suggest that sinusoidal dilatation is irreversible.
...
PMID:Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1982. Tender hepatomegaly in a 29-year-old woman. 711 Feb 74
Fatal
hepatitis
associated with intake of carbamazepine occurred in two females, 37 and 23 years old. The former used carbamazepine to prevent alcohol withdrawal symptoms.
She
had also been treated with disulfiram. The latter had used the drug as the only medication for epilepsy. This report supports the view that carbamazepine may induce serious hepatic damage.
...
PMID:Fatal carbamazepine-associated hepatitis. Report of two cases. 731 33
A 75-year-old female, born in Tochigi Prefecture, was admitted because of lumbago in August of 1991. The leukocyte count was 11,800/microliters with 22.5% atypical lymphocytes. We demonstrated a lymphocyte surface marker, ATL-associated antigen, and proviral DNA. We also identified 2.60 g/dl of serum monoclonal protein, found to be IgG, lambda type, and punched out lesions in the skull. We made a diagnosis of ATL.
She
was also a HBV carrier. The patient was treated with a modification of CHOP therapy, because of increasing atypical lymphocytes in the peripheral blood in November of 1992.
She
died of acute hepatitis, suddenly, in March of 1993. Autopsy revealed multiple myeloma, fulminant
hepatitis
and occult thyroid cancer in addition to ATL.
...
PMID:[A HBV carrier with fulminant hepatitis complicated by ATL, multiple myeloma and thyroid cancer]. 756 12
We report the occurrence of rhabdomyolysis and
hepatitis
in a 17-year-old girl after the ingestion of up to 10.8 g of isoniazid. The initial isoniazid concentration in the blood was 1,230 mmol/L. There were no findings indicating the ingestion of other substances known to be associated with rhabdomyolysis. In addition to rhabdomyolysis (peak creatine phosphokinase 88,000 U/L), the patient had a significant elevation of her liver enzymes (peak aspartate aminotransferase 1,980 U/L).
She
recovered completely without evidence of liver or renal damage. Rhabdomyolysis and isoniazid-induced
hepatitis
are complications that should be considered when caring for patients with acute isoniazid ingestion.
...
PMID:Isoniazid-associated rhabdomyolysis. 766 61
This is a report on a case of autoimmunehepatopathy with misleading virus serology: A 34-year old female patient presented with abdominal signs of hepatopathy at Graz University School of Medicine.
Hepatitis
-C virus (HCV) serology was strongly positive indicating virus contact. The cellular activation was elevated, additionally increased ds-DNA-titer and mitochondrial antibody titres including the subfraction M2 were increased. In view of the differential diagnosis and therapeutic consequences molecular biology was used for additional information and a PCR carried out. The latter excluded infection with HCV confirming a false positive virus serology. The patient was treated with ursodesoxycholic acid, steroids and enzymes.
She
improved and showed no viral exposure. We conclude, that molecular biology represents an essential tool for the diagnosis of some selected critical cases of autoimmune-diseases such as autoimmune hepatopathy with false positive virus serology, if the underlying etiopathogenesis is not clear.
...
PMID:[Expanded diagnostic possibilities for diagnosis and differential diagnosis of autoimmune hepatopathies using polymerase chain reaction (PCR)]. 778 84
Unconventional medical practices, including the use of herbal remedies, are prevalent in the United States. Chaparral is an herbal preparation made from a desert shrub and used for its antioxidant properties. We report the case of a 60-year-old woman who took chaparral for 10 months and developed severe
hepatitis
for which no other cause could be found. Despite aggressive supportive therapy, the patient deteriorated and required orthotopic liver transplantation.
She
is now well, more than 1 year after her transplant. This case suggests that chaparral can cause serious liver injury and fulminant hepatic failure. Herbal medications should be considered as potential causes of liver toxicity.
...
PMID:Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. 783 70
A 45-year-old hepatitis B surface antigen carrier had an allograft kidney transplantation and maintenance immunosuppression with cyclosporin A and prednisolone. Six months later, she experienced a rapidly progressive hepatic failure manifested by elevation of serum bilirubin level, prolongation of prothrombin time, and mild to modest increase of serum aminotransferase levels.
She
died in 6 weeks. Postmortem liver histology showed canalicular and cellular cholestasis and ground-glass appearance and ballooning of most hepatocytes, but only mild inflammatory cell infiltration. Immunohistochemical staining showed massive loads of hepatitis B surface and core antigens in the hepatocytes and extensive periportal fibrosis. The whole picture was compatible with fibrosing cholestatic
hepatitis
described in hepatitis B virus-infected liver transplant. Sequencing of the hepatitis B virus genome amplified from the patient's serum indicated a precore mutant but few mutations in the core, pre-S, and S genes. Little inflammatory reaction was observed histologically despite HLA compatibility, a situation differing from that in liver transplant. This observation indicates that fibrosing cholestatic
hepatitis
may also occur in non-liver transplant setting.
...
PMID:Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation. 792 15
A 36-year-old woman was scheduled for Cesarean section under spinal anesthesia.
She
was a carrier of
hepatitis
-B-virus and diabetic.
She
was complaining of low back pain. Spinal anesthesia was performed in the left lateral decubitus position. Because lumbar puncture in the midline was difficult, left paramedian approach was tried. Then she began to complain of right leg pain. Another attempt was made at other site, but her pain was not relieved. After confirming drop of blood-tinged cerebrospinal fluid, 0.3% dibucaine 2.0 ml was injected. Sensory anesthesia was assessed by pin-prick, but anesthesia was not effective. Then epidural catheter was inserted at Th12-L1 using median approach.
She
received 1.0% lidocaine 15 ml. However, sensory anesthesia was insufficient (Th4-Th12). Therefore O2-N2O was administered in addition to regional anesthesia. After the delivery, she still complained of low back pain. Later examination revealed metastatic bone tumor of L2 from hepatoma. This case suggests that in a patient with such incomplete spinal or epidural anesthesia and neurological finding, vertebral metastatic tumor should be ruled out.
...
PMID:[A case of vertebral metastasis revealed by incomplete spinal analgesia for cesarean section]. 793 77
Complete congenital heart block is a serious complication of neonatal lupus erythematosus which most often occurs in children of mothers suffering from connective tissue disease. We report the occurrence of complete congenital heart block associated with autoimmune
hepatitis
(SLA-positive). A 32-year-old woman was treated for more than 10 years for autoimmune
hepatitis
(SLA-/ANA-positive) and remained in clinical remission under immunosuppressive therapy.
She
showed an MHC-haplotype typical for autoimmune
hepatitis
(A1, B8, DR3). After a normal first pregnancy, an emergency caesarean section was performed in the 32nd week of her second pregnancy because of fetal bradycardia. The child died a few hours after delivery of complete congenital AV-block. Retrospective analysis of the maternal serum showed the emergence of SS-A/Ro-antibodies prior to the second pregnancy. The maternal serum antibodies were reactive with the 52 kD SS-A/Ro-antigen, as demonstrated by immunoblot employing recombinant SSA/Ro-antigen. The occurrence of complete congenital heart block has been shown to be associated with the presence of SS-A/Ro antibodies as well as the MHC-haplotype DR3. With respect to this genetic linkage, pregnant patients with autoimmune
hepatitis
and the MHC-haplotype DR3 should be examined for the presence of SS-A/Ro-antibodies. They should be closely followed during pregnancy to enable early detection of the development of congenital heart block, as prevention by plasmapheresis plus dexamethasone may be possible at an early stage.
...
PMID:Complete congenital heart block in autoimmune hepatitis (SLA-positive). 798 13
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>